Gaudium IVF and Women Health Ltd
- Market cap
- ₹ 668 Cr.
- P/E
- 31x
- P/B
- 4.48x
- 52-week range
- 69.18 – 163.18
- ROE
- 25%
- ROCE
- 29%
- Dividend yield
- 0%
- Debt / equity
- 0.16
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- NSE, BSE
About
Gaudium IVF and Women Health Limited is an India-based company which is engaged in offering a complete range of specialized fertility and reproductive health services. Its advanced treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all its treatments are designed to address a variety of infertility challenges for both male and female. The Company also offers comprehensive gynecological care, including PCOD/PCOS and endometriosis. Further, it provides high-risk pregnancy management for women with complex fertility histories or health conditions, which includes fertility wellness programs, offering nutritional counseling and psychological support for couples undergoing treatment. It also offers laparoscopic and hysteroscopic surgery for the diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT).
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Gaudium IVF and Women Health Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)31 against a typical 21: pricier than most peers (1st = cheapest).19th of 34
- Sales growth+9.1% against a typical +19.1% from a year earlier.23rd of 31
- Profit growth−42% against a typical +25.2% from a year earlier.19th of 24
- Share price, 3 months−30.6% against a typical −7.7%.32nd of 33
- Size₹ 667.9 Cr. market value against a typical ₹ 83 Cr. (1st = largest).11th of 34
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 13 Aug 2026 | Financial Results | Gaudium IVF and Women Health Limited has informed the Exchange about the Board Meeting scheduled to be held on August 13, 2026, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026 |
| 28 May 2026 | Financial Results | Gaudium IVF and Women Health Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026, inter alia, to consider and approve the Audited Standalone and Consolidated Financial Statements/Results of the Company for the quarter and year ended March 31, 2026. |
| 18 Mar 2026 | Financial Results | To consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 14 | 27 | 18 | 32 | 25 | 30 | 19 |
| Expenses | 9 | 18 | 13 | 18 | 18 | 18 | 17 |
| Operating Profit | 6 | 9 | 5 | 14 | 7 | 12 | 2 |
| OPM % | 39.3% | 32.4% | 29% | 43.4% | 26.8% | 40.1% | 12.5% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
| Profit before tax | 5 | 8 | 4 | 13 | 5 | 10 | 2 |
| Tax % | 27.7% | 21% | 24% | 26.6% | 27% | 19.8% | 27.8% |
| Net Profit | 3 | 6 | 3 | 9 | 4 | 8 | 2 |
| EPS in Rs | 0.55 | 1.05 | 0.5 | 1.53 | 0.59 | 1.15 | 0.24 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 33%
- TTM
- 48%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 22%
- TTM
- 28%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 41%
- 3 Years
- 34%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Gaudium IVF and Women Health Ltd | ₹ 99.27 | ₹ 668 Cr. | 31x | 4.5x | 25% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Manika Khanna
- Executive Chairman, Managing Director
- Rakesh Kumar Sharma
- Chief Financial Officer
- Naveen Kumar
- Company Secretary, Compliance Officer
- Peeyush Khanna
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.